BURLINGAME, Calif., July 24, 2014 /PRNewswire/ -- ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and maintain a new, state-of-the-art Cancer Institute in Ibadan, Nigeria. Under the first of the 4-phase project, ECC will conduct feasibility studies and prepare scoping documents and funding applications. UCH Ibadan intends to finance and develop the Cancer Institute using funding from Export-Import Bank and other financial institutions.
The Cancer Institute will be an innovative, holistic diagnostic center, including oncological screening, diagnosis, treatment, prevention, training, and research.
"Medical infrastructure and accessibility are critical steps in leading the fight against disease throughout Africa," comments ECC's President & CEO, Manjiv S. Vohra, PE, DBIA. "UCH Ibadan and its new Cancer Institute will provide premier oncological services, touching the lives of millions of people and their families affected by cancer. We are proud to lead the development of this ground-breaking institution."
Professor Temitope Oluwagbenga Alonge, MBBS Ibadan, MD Leicester, FRCS Edinburgh, FWACS, UCH Ibadan Chief Medical Director, represented the Board of Management during the signing. He stated, "Cancer is a leading cause of death at UCH Ibadan. Accurate diagnosis of cancer is germane to targeted treatment modalities. Our partnership with ECC, a world-class, renowned, and reputable company, will no doubt ensure a more accurate diagnosis, and by extension, appropriate and targeted treatment of cancers, as well as offer opportunities for cutting-edge research and the development of protocols in UCH, Nigeria, an
Copyright©2014 PR Newswire.
All rights reserved